Guest guest Posted January 14, 2008 Report Share Posted January 14, 2008 Interim Analysis Supports Continuation of Cell Genesys' VITAL-1 Phase 3 Clinical Trial of GVAX Immunotherapy for Prostate Cancerhttp://money.cnn.com/news/newsfeeds/articles/prnewswire/AQM079A14012008-1.htm -- Emersonwww.flhw.org Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.